Somnics key facts
- Developer of a sleep therapy system designed to offer support to patients suffering from sleep-disordered breathing.
- It has raised $21.2M; the latest was Accelerator/Incubator in May 2024.
- Notable investors include MedTech Innovator, National Development Fund of Taiwan, Ampoc Far-East Company, Top Taiwan Venture Capital Group, TransPacific Venture Partners — 6 tracked in total.
- Status: Privately Held (backing).
- ·Watch Somnics: the Monday email on marks, rounds and moves
Somnics funding rounds
No funding rounds for Somnics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Somnics investors
6 investors are on record for Somnics, including MedTech Innovator, National Development Fund of Taiwan, Ampoc Far-East Company and Top Taiwan Venture Capital Group.
About Somnics
Developer of a sleep therapy system designed to offer support to patients suffering from sleep-disordered breathing. The company's main product iNAP is a sleep therapy system that utilizes oral negative pressure technology to treat obstructive sleep apnea patients, providing clients with a comfortable and discreet treatment for patients of Obstructive Sleep Apnea.
- Sector
- Healthcare
- HQ
- Zhubei, Taiwan
- Founded
- 2010
- Employees
- 48
- Website
- somnics.com/
- Ownership
- Privately Held (backing)
Is this your company? Profiles are maintained at PrivateMarketView, the data platform behind this page — sign in with your work email to keep it current, or tell us what's wrong.
Somnics doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.